Accès à distance ? S'identifier sur le proxy UCLouvain
Pharmacokinetics of Glecaprevir/Pibrentasvir in children with chronic HCV infection: interim analysis of part 2 of the Dora study
Primary tabs
- Open access
- 349.05 K
Jonas, Maureen M.
[Boston Children's Hospital]
Lon, Hoi Kei
[Abbvie]
Rhee,Susan
[Abbvie]
Gilmour, Susan M
[Sollery Children's Hospital, Alberta, Canada]
Gonzalez-Peralta, Regino P.
[Adventhealth for Children, Orlando, Florida]
Sokal, Etienne
[UCL]
| Document type | Communication à un colloque (Conference Paper) – Poster, Abstract |
|---|---|
| Access type | Accès libre |
| Publication date | 2019 |
| Language | Anglais |
| Conference | "The Liver Meeting AASLD (American Association of the Study of Liver Diseases)", Boston, USA (du 08/11/2019 au 12/11/2019) |
| Journal information | "Hepatology" - Vol. November, p. Abstract 1551 (2019) |
| Peer reviewed | yes |
| issn | 0270-9139 |
| Publication status | Publié |
| Affiliations |
UCL
- SSS/IREC/PEDI - Pôle de Pédiatrie UCL - (SLuc) Service de gastro-entérologie et hépatologie pédiatrique |
| Links |
| Bibliographic reference | Jonas, Maureen M. ; Lon, Hoi Kei ; Rhee,Susan ; Gilmour, Susan M ; Gonzalez-Peralta, Regino P. ; et. al. Pharmacokinetics of Glecaprevir/Pibrentasvir in children with chronic HCV infection: interim analysis of part 2 of the Dora study.The Liver Meeting AASLD (American Association of the Study of Liver Diseases) (Boston, USA, du 08/11/2019 au 12/11/2019). In: Hepatology, Vol. November, p. Abstract 1551 (2019) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/222808 |